🔗 Share this article

While the United States proceeds with historic adjustments to its vaccination guidelines, a particular individual appears in a surprising turn: Tracy Beth Høeg, a US-based sports physician and epidemiologist who rose to prominence by questioning coronavirus vaccines throughout the pandemic and has focused upon possible deaths following Covid vaccination in her recent tenure at the US Food and Drug Administration (FDA).

Planned Changes to Pediatric Immunization Schedule

Public health authorities planned to reveal radical changes to the pediatric vaccination calendar earlier this month, synchronizing the US with the Danish immunization schedule, sources say – a significant shift that would place the US out of step with a large portion of the global community with little proof for public health gain. This reveal has been delayed until the coming year.

Instead of the director of the vaccine center, Dr. Høeg is set to present at the meeting. She was recently named temporary leader of the FDA’s CDER, the fifth individual to head the office this calendar year.

A New Direction at the FDA

This interim role might represent a strengthened alliance between the drug and vaccine divisions as Dr. Høeg and Dr. Prasad consolidate power at the regulatory agency – and it points to a increased emphasis upon reevaluating already-approved immunizations at the FDA.

Høeg has frequently advocated for halting specific childhood vaccine recommendations in the US in order to be more in line with Denmark's approach, a nation with universal health coverage and a population approximately the size of Wisconsin’s.

In her initial statements, she has continued to focus on vaccination policy – usually the responsibility of Prasad, chief of the FDA’s CBER – instead of medication approval.

Questions Over Qualifications

Dr. Høeg has little discernible track record in drug development, approval processes or leadership, which has been standard for former leaders of the CBER. She has worked at the FDA as a senior adviser to the commissioner and the vaccine center since spring.

“She appears not to have any of the qualifications” for leading the CDER, said Dr. Jonathan Howard. “She lacks experience running a clinical trial. She lacks experience in running a sizeable institution. She has no expertise in drug approvals.”

Past directors of the center would “be deeply familiar with laws and regulations and the research of drug development”, said Dr. Janet Woodcock. “Clearly, she doesn’t have the type of experience that previous people who headed CBER have had.”

The drug center has an vast workload at the FDA, Woodcock pointed out.

“The public just pays attention on the new drug program, but the generic drug division authorizes numerous generic drugs. There is also a biosimilars program, OTC medication office and so forth, and all of those need to be looked after,” Woodcock explained. “The responsibility you neglect, that is precisely what that I always told people is going to cause problems.”

Furthermore, a major management element to the position, which supervises over 5,000 employees. “It’s a huge leadership role, if you do it right,” Woodcock concluded.

Response and Disputed Programs

When asked about questions about Høeg’s credentials and whether this appointment represents greater collaboration among FDA leaders on immunizations, a spokesperson responded that the “questions are based on inaccurate assumptions”.

“Her experience matches the responsibilities of her role,” the official stated, pointing to the time Dr. Høeg spent guiding the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

As the temporary head, Høeg assumes responsibility for the commissioner’s new priority voucher program, a disputed one-day medication authorization process that allegedly concerned her former heads. “By what process are these therapies being selected for this voucher program? Who takes the calls?” Howard asked. “There’s a lot of lack of transparency going on at the regulatory body right now.”

Broadly speaking, he said, “the agency looks to be trending towards laxer regulations of most medications, aside from immunizations.”

Established History on Vaccines

With vaccines, Høeg has a more established, if problematic, past, Howard observe. She released a research paper using non-validated crowd-sourced reports to estimate the rate of myocarditis after Covid vaccination. She counseled the state of Florida top health official Joseph Ladapo, who was said to have altered data to suggest Covid vaccinations are pose a greater threat than they are.

Part of her “desired changes” for the incoming administration encompassed revising rules for novel immunizations and ending “optional” vaccines, she stated after the election on a online show. At the agency, Høeg has reportedly suggested barring teenage boys from getting COVID-19 vaccinations.

“She’s an complete true believer who starts off with her preconceived notions and works backwards to fit the data in a extremely disingenuous, dishonest fashion,” Dr. Howard argued.

Taking Control and a “Revenge Tour”

Høeg joined fellow dissenters, {like|